We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MEDNAX (MD) Acquires Maternal-Fetal Practice in Florida
Read MoreHide Full Article
Share price of MEDNAX Inc (MD - Free Report) edged up nearly 1% following the company’s announcement of the acquisition of a privately held physician group practice -- Maternal Fetal Medicine of Southwest Florida.
Notably, the buyout closely follows MEDNAX’ recent takeover of ‘Associated Anesthesiologists’ in Nevada, following the second-quarter earnings release.
The company disclosed that the latest acquisition has been executed entirely in cash and is expected to prove immediately accretive to earnings. However, all other terms of the deal have been kept under wraps.
Maternal Fetal Medicine currently employs a broad range of specialists who provide high-end services like perinatology and sonography. The practice has four physicians, 11 sonographers and 26 other clinical and administrative staff across four patient offices and six hospitals.
Buyout Synergies
This deal is likely to expand MEDNAX’s presence and help it fortify its market position in southwest Florida. Apart from pediatric and other multiple specialty services, the acquisition will allow the company to provide high-risk ‘ultrasound maternal-fetal’ and neonatal medicines to potential patients in the region.
A glimpse of the recent buyouts reveal that the company has successfully closed three acquisitions in the just-reported second quarter. Moreover, to date in 2016, the company has acquired ten physician practices, including Maternal-Fetal Practice in Florida.
Taking the growing awareness in the neonatal, fetal and related ancillary markets into consideration, we believe the recent acquisition will help MEDNAX tap in on significant opportunities going ahead.
Notably, data from ‘Markets And Markets’ reveal that the global fetal (labor & delivery) and neonatal care equipment market is poised to grow at a CAGR of 6.5% to reach $8.61 billion by 2020. Meanwhile, the ultrasound market is also set for a strong growth with a CAGR of 5.5%, likely to be worth $6.86 billion by 2020.
Zacks Rank & Key Picks
Currently, MEDNAX has a Zacks Rank #3 (Hold).
Better-ranked stocks in the broader medical sector include CryoLife Inc. , Masimo Corporation (MASI - Free Report) and NuVasive Inc. . Notably, all the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
MEDNAX (MD) Acquires Maternal-Fetal Practice in Florida
Share price of MEDNAX Inc (MD - Free Report) edged up nearly 1% following the company’s announcement of the acquisition of a privately held physician group practice -- Maternal Fetal Medicine of Southwest Florida.
Notably, the buyout closely follows MEDNAX’ recent takeover of ‘Associated Anesthesiologists’ in Nevada, following the second-quarter earnings release.
The company disclosed that the latest acquisition has been executed entirely in cash and is expected to prove immediately accretive to earnings. However, all other terms of the deal have been kept under wraps.
Maternal Fetal Medicine currently employs a broad range of specialists who provide high-end services like perinatology and sonography. The practice has four physicians, 11 sonographers and 26 other clinical and administrative staff across four patient offices and six hospitals.
Buyout Synergies
This deal is likely to expand MEDNAX’s presence and help it fortify its market position in southwest Florida. Apart from pediatric and other multiple specialty services, the acquisition will allow the company to provide high-risk ‘ultrasound maternal-fetal’ and neonatal medicines to potential patients in the region.
A glimpse of the recent buyouts reveal that the company has successfully closed three acquisitions in the just-reported second quarter. Moreover, to date in 2016, the company has acquired ten physician practices, including Maternal-Fetal Practice in Florida.
MEDNAX INC Price
MEDNAX INC Price | MEDNAX INC Quote
Our Take
Taking the growing awareness in the neonatal, fetal and related ancillary markets into consideration, we believe the recent acquisition will help MEDNAX tap in on significant opportunities going ahead.
Notably, data from ‘Markets And Markets’ reveal that the global fetal (labor & delivery) and neonatal care equipment market is poised to grow at a CAGR of 6.5% to reach $8.61 billion by 2020. Meanwhile, the ultrasound market is also set for a strong growth with a CAGR of 5.5%, likely to be worth $6.86 billion by 2020.
Zacks Rank & Key Picks
Currently, MEDNAX has a Zacks Rank #3 (Hold).
Better-ranked stocks in the broader medical sector include CryoLife Inc. , Masimo Corporation (MASI - Free Report) and NuVasive Inc. . Notably, all the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>